These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3048452)
1. Site-protective agents. Marks IN Baillieres Clin Gastroenterol; 1988 Jul; 2(3):609-20. PubMed ID: 3048452 [No Abstract] [Full Text] [Related]
2. Mucosal protective agents in the long-term management of gastric ulcer. Marks IN; Boyd E Med J Aust; 1985 Feb; 142 Spec No():S23-5. PubMed ID: 3841579 [No Abstract] [Full Text] [Related]
3. Pharmacological and clinical aspects of some drugs used in peptic ulcer treatment. Abrahamsson H; Dotevall G Scand J Gastroenterol Suppl; 1979; 55():117-20. PubMed ID: 395633 [TBL] [Abstract][Full Text] [Related]
4. [Selective and locally-acting drugs in the treatment of peptic ulcer]. Ryss ES Klin Med (Mosk); 1984 Jul; 62(7):10-8. PubMed ID: 6384654 [No Abstract] [Full Text] [Related]
5. [Liquorice preparations in the treatment of peptic ulcer (author's transl)]. Ronský R Cesk Gastroenterol Vyz; 1975 Oct; 29(7):463-70. PubMed ID: 1192489 [No Abstract] [Full Text] [Related]
6. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease. May B Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280 [TBL] [Abstract][Full Text] [Related]
7. [Clinical trial of Alcid V in peptic ulcer therapy]. Vŭrbanov G; Rusinov E; Danev I; Glinkova V; Panecheva K Vutr Boles; 1981; 20(5):27-34. PubMed ID: 7034375 [No Abstract] [Full Text] [Related]
8. [Undesirable effects of Biogastrone in the treatment of peptic ulcer (author's transl)]. Zelenková J; Toman R; Svoboda M; Svihovec J Cesk Gastroenterol Vyz; 1976 Oct; 30(7):427-33. PubMed ID: 797473 [No Abstract] [Full Text] [Related]
9. [Current trends in medical therapy of gastroduodenal ulcer]. Grassi M; Fraioli A; Messina B Clin Ter; 1987 Dec; 123(6):475-86. PubMed ID: 2902954 [No Abstract] [Full Text] [Related]
10. The medical management of peptic ulcer. Shearman DJ; Hetzel D Annu Rev Med; 1979; 30():61-79. PubMed ID: 45409 [No Abstract] [Full Text] [Related]
11. Drugs for treatment of peptic ulcers. Med Lett Drugs Ther; 1991 Nov; 33(858):111-4. PubMed ID: 1682791 [No Abstract] [Full Text] [Related]
12. The pharmacology of peptic ulcer disease. Ippoliti A; Peterson W Clin Gastroenterol; 1979 Jan; 8(1):53-67. PubMed ID: 369747 [No Abstract] [Full Text] [Related]
13. Pharmacologic options for the control of peptic ulcer disease. Levine JB Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108 [No Abstract] [Full Text] [Related]
14. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate. Bianchi Porro G; Parente F J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753 [TBL] [Abstract][Full Text] [Related]
15. [Therapy of peptic ulcer with cytoprotective substances]. Fortunat W Wien Med Wochenschr; 1983; 133(4-5):94-8. PubMed ID: 6407215 [No Abstract] [Full Text] [Related]
16. [Advances in ulcer therapy]. Domschke W Fortschr Med; 1983 Apr; 101(13):575-82. PubMed ID: 6133827 [No Abstract] [Full Text] [Related]